AI assistant
Nuvation Bio Inc. — Director's Dealing 2025
Nov 24, 2025
32154_dirs_2025-11-24_3a313187-0ac4-448e-bcb4-995c425eed68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2025-11-20
Reporting Person: Hattersley Gary (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-20 | Class A Common Stock | M | 69051 | $1.74 | Acquired | 69051 | Direct |
| 2025-11-20 | Class A Common Stock | S | 69051 | $7.227 | Disposed | 0 | Direct |
| 2025-11-20 | Class A Common Stock | M | 300000 | $1.94 | Acquired | 300000 | Direct |
| 2025-11-20 | Class A Common Stock | S | 300000 | $7.227 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | Stock Option (Right to Buy) | $1.74 | M | 69051 | Disposed | 2030-01-21 | Class A Common Stock (69051) | Direct |
| 2025-11-20 | Stock Option (Right to Buy) | $1.94 | M | 300000 | Disposed | 2033-02-27 | Class A Common Stock (300000) | Direct |
Footnotes
F1: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years.
F3: Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.